Medical supply firm Medline jumps more than 25% in debut after biggest IPO of 2025

Go to Article

Medline priced at $29 per share on Tuesday, raising $6.26 billion to cap off a strong year for new listings and bolster optimism about 2026.



Comment on this Article Via Your Disqus Account